首页> 美国卫生研究院文献>JBRA Assisted Reproduction >Zika virus and Assisted Reproductive Technology: to test or not totest that is the question. Is it an unnecessary cost? The first two months ofmandatory testing in an outbreak area in Rio de Janeiro Brazil
【2h】

Zika virus and Assisted Reproductive Technology: to test or not totest that is the question. Is it an unnecessary cost? The first two months ofmandatory testing in an outbreak area in Rio de Janeiro Brazil

机译:寨卡病毒和辅助生殖技术:测试还是不测试测试这就是问题。这是不必要的费用吗?的前两个月在巴西里约热内卢爆发地区进行强制性检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectiveInfection by the Zika virus is a Public Health Emergency of International Concern as defined by the World Health Organization. Resolution no. 72, issued by the Collegiate Board of the Brazilian Health Surveillance Agency (ANVISA) on March 30, 2016, made ZKV testing mandatory prior to procedures involving germ cells and tissues. This paper aims to discuss the aforementioned Resolution from the standpoint of evidence and cost-effectiveness of the measures taken within the first two months of mandatory testing.
机译:感染寨卡病毒是世界卫生组织定义的国际关注的突发公共卫生事件。决议号由巴西健康监视局(ANVISA)大学董事会于2016年3月30日发布的第72条规定,在涉及生殖细胞和组织的手术之前,必须进行ZKV检测。本文旨在从证据和强制测试的前两个月内所采取措施的成本效益的角度讨论上述决议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号